Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2012
06/26/2012US8207137 administering a therapeutically effective amount of an active agent selected from the group consisting of a protein substance including all or part of a disintegrin domain of an adamalysin or a derivative thereof
06/26/2012US8206947 Human transmembrane proteins
06/26/2012US8206727 Oral suspension of prednisolone acetate
06/26/2012US8206719 KDR peptides and vaccines comprising the same
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
06/26/2012CA2513526C Method and apparatus for correcting vision using an electro-active phoropter
06/26/2012CA2468082C Assay for screening candidate drugs for the treatment of inflammatory diseases
06/26/2012CA2371689C Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatment
06/23/2012CA2762530A1 Degradation-stabilised, biocompatible collagen matrices
06/21/2012WO2012082921A1 Cellular activation insulin therapy
06/21/2012WO2012081711A1 Cell migration modulator
06/21/2012WO2012081531A1 Disease inhibiting agent
06/21/2012WO2012081273A1 Disease inhibiting agent
06/21/2012WO2012080992A2 Essential oil of bupleurum
06/21/2012WO2012080728A1 Imidazo [4, 5 -c] quinolin- 1 -yl derivative useful in therapy
06/21/2012WO2012080685A1 Extract of cassia alata against stretchmarks
06/21/2012WO2012080333A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
06/21/2012WO2012080223A1 Use of glycosaminoglycan lipoate esters in the trichology field
06/21/2012WO2012079121A1 Improved mineral based composition and methods of use
06/21/2012WO2012047733A3 Treatment of acne by conditioned media
06/21/2012WO2012030993A3 Skin compositions and methods of use thereof
06/21/2012WO2012020989A9 Pharmaceutical or cosmetic composition containing nicotinic acid adenine dinucleotide phosphate or derivative thereof
06/21/2012WO2011090741A9 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
06/21/2012US20120157546 Compositions Containing Aromatic Aldehydes and Their Use in Treatments
06/21/2012US20120157545 Methods for treating skin disorders with topical nitrogen mustard compositions
06/21/2012US20120157539 Nuclear receptor binding agents
06/21/2012US20120157528 Leave-on nonsolid skin conditioning compositions containing 12-hydroxystearic acid and ethoxylated hydrogenated castor oil
06/21/2012US20120157527 Cosmetic use of a jasmonic acid derivative for treating the hair and the scalp
06/21/2012US20120157525 Treating eczema and/or psoriasis
06/21/2012US20120157523 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
06/21/2012US20120157502 Phenanthrenone compounds, compositions and methods
06/21/2012US20120157487 Sulfur derivatives as chemokine receptor modulators
06/21/2012US20120157481 Tricyclic pyrimidine derivatives as wnt antagonists
06/21/2012US20120157467 Composition and use for phosphodiesterase inhibitors
06/21/2012US20120157446 Medical use
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157431 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
06/21/2012US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/21/2012US20120157428 Bromodomain inhibitors and uses thereof
06/21/2012US20120157413 Phosphorous derivatives as chemokine receptor modulators
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157411 2-amino-4-arylthiazole compounds as trpai antagonists
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157387 Orally bioavailable d-gamma-glutamyl-d-tryptophan
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120157371 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
06/21/2012US20120156315 Composition for Treating Vitiligo or Canities Comprising Extract from Sophora Japonica as Active Ingredient
06/21/2012US20120156309 Using Aqueous Oxygenation to Improve Animal Health & Wellness
06/21/2012US20120156307 Medical uses of nanoclustered water
06/21/2012US20120156283 Methods and Compositions for Wound Treatment
06/21/2012US20120156251 Cationic oil-in-water emulsions
06/21/2012US20120156213 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
06/21/2012US20120156201 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
06/21/2012US20120156198 Antibodies against IL-18R1 and uses thereof
06/21/2012US20120156192 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
06/21/2012US20120156184 Methods and materials for treating burn injuries
06/21/2012US20120156171 Cosmetic and/or dermatological composition for prevention and/or treatment of sensitive or dry skin
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156163 Methods of decreasing sebum production in the skin
06/21/2012US20120156144 Foamable Compositions, Kits and Methods for Hyperhidrosis
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012US20120156137 Composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them
06/21/2012CA2821962A1 Methods of decreasing sebum production in the skin
06/21/2012CA2821715A1 Chimeric fibronectin matrix mimetics and uses thereof
06/21/2012CA2821598A1 Use of glycosaminoglycan lipoate esters in the trichology field
06/21/2012CA2821219A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
06/21/2012CA2820871A1 Disease inhibiting agent
06/20/2012EP2465928A1 Treatment of Th17-mediated diseases
06/20/2012EP2465508A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/20/2012EP2465507A1 Oligosaccharide composition for treating skin diseases
06/20/2012EP2465503A1 Pharmaceutical solution of cetirizine hydrochloride
06/20/2012EP2465488A1 Preparation for external application to skin, skin whitening agent, antioxidant agent, and anti-aging agent
06/20/2012EP2464667A2 N-acylated octasaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2464359A2 N-sulfated oligosaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2464357A2 Vitamin d3 and analogs thereof for treating alopecia
06/20/2012EP2464232A1 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2102169B1 Indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/20/2012EP1735348B1 Human anti-epidermal growth factor receptor antibody
06/20/2012CN102510865A Nitrogen-containing spiro-ring compound and medicinal use of same
06/20/2012CN102505006A Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102503959A Tricyclic compounds and preparation method thereof, and medicinal composition containing compounds and application thereof
06/20/2012CN102503932A Novel gas signal molecule donator and preparation method and use thereof
06/20/2012CN102503899A Crystal of phenylalanine derivative, process for producing the same and use thereof
06/20/2012CN102503896A Methylacryloyl-benzimidazole (sulfur) ketone derivative and application of serving as antibacterial agent thereof
06/20/2012CN102499981A Compositions and methods for topical application and transdermal delivery of botulinum toxins
06/20/2012CN102499974A Medicament for inhibiting skin fungi and preparation method thereof
06/20/2012CN102499961A Traditional Chinese medicinal composition drug for external use for treating ecthyma and preparation method thereof
06/20/2012CN102499956A Plaster for burns and scalds and preparation method thereof
06/20/2012CN102499949A Ointment for treating chapped hands and feet
06/20/2012CN102499947A Traditional Chinese medicine preparation for treating bedsore and inflammatory pain around knee joint and preparation method thereof
06/20/2012CN102499941A Decontamination bag for skin radioactive contamination
06/20/2012CN102499929A 42-(Dimethylphosphinate)rapamycin solid composition and coating method thereof
06/20/2012CN102499915A Drug with Chinese rhubarb acid compound and preparation method of clathrate compound of Chinese rhubarb acid compound
06/20/2012CN102499541A Red bayberry health-care cushion
06/20/2012CN102178742B External medicinal powder for treating bromhidrosis
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 1065